Mar 01, 2018 12:28 pm UTC| Business
LONDON, March 01, 2018 -- LONSIN Capital Limited, together with its affiliates, representing over 5% of the shares outstanding of Asia Pacific Wire and Cable ("APWC", ticker “APWC US") on February 23, 2018 wrote to the...
Templeton Global Income Fund (“GIM”) Announces Distribution
Mar 01, 2018 12:14 pm UTC| Business
FT LAUDERDALE, Fla., March 01, 2018 -- Templeton Global Income Fund (NYSE:GIM) today announced a monthly distribution from net investment income of $0.0174 per share, payable on March 29, 2018, to shareholders of record...
BRIDGE Energy Group to Share Thought Leadership at PowerForward Ohio PUC Commission Proceedings
Mar 01, 2018 12:10 pm UTC| Business
NEWTON, Mass., March 01, 2018 -- BRIDGE Energy Group (BRIDGE) today announced that Sandy Simon, VP of Transmission Distribution has been selected to present at the PowerForward Ohio, Public Utilities Commission...
Stone Point Capital, the Karfunkel Family and the CEO to Acquire AmTrust Financial Services, Inc.
Mar 01, 2018 12:07 pm UTC| Business
AmTrust shareholders to receive $13.50 per share in cash Transaction represents a premium of 33% to AmTrust’s unaffected closing common stock price on January 9, 2018 NEW YORK, March 01, 2018 -- AmTrust Financial...
AmTrust Financial Files SEC Form 12b-25
Mar 01, 2018 12:06 pm UTC| Business
NEW YORK, March 01, 2018 -- AmTrust Financial Services, Inc. (Nasdaq:AFSI) (“AmTrust” or the “Company”) announced today that it filed a Form 12b-25 with the Securities and Exchange Commission, providing the Company an...
Mar 01, 2018 12:05 pm UTC| Business
SALT LAKE CITY, March 01, 2018 -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, continues to demonstrate an unmatched commitment to hereditary cancer risk assessment...
G1 Therapeutics to Present at Investor Conferences in March 2018
Mar 01, 2018 12:04 pm UTC| Business
RESEARCH TRIANGLE PARK, N.C., March 01, 2018 -- G1 Therapeutics, Inc. (Nasdaq:GTHX), a clinical-stage oncology company, today announced that Chief Executive Officer Mark Velleca, M.D., Ph.D., will present a company...